The Associated of the Risk of IVIG Resistance in Kawasaki Disease with ZNF112 Gene and ZNF180 Gene in a Southern Chinese Population

References

• Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–2771. doi:10.1161/01.CIR.0000145143.19711.78
   PubMed Web of Science ®Google Scholar
• Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018;6:374. doi:10.3389/fped.2018.00374
   PubMed Web of Science ®Google Scholar
• Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100(11):1084–1088. doi:10.1136/archdischild-2014-307536
   PubMed Web of Science ®Google Scholar
• McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi:10.1161/CIR.0000000000000484
   PubMed Web of Science ®Google Scholar
• Phuong LK, Curtis N, Gowdie P, Akikusa J, Burgner D. Treatment options for resistant Kawasaki disease. Paediatr Drugs. 2018;20(1):59–80. doi:10.1007/s40272-017-0269-6
   PubMed Web of Science ®Google Scholar
• Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004;364(9433):533–544. doi:10.1016/S0140-6736(04)16814-1
   PubMed Web of Science ®Google Scholar
• Sundel RP. Kawasaki disease. Rheum Dis Clin North Am. 2015;41(1):63–73. doi:10.1016/j.rdc.2014.09.010
   PubMed Web of Science ®Google Scholar
• Duignan S, Doyle SL, McMahon CJ. Refractory Kawasaki disease: diagnostic and management challenges. Pediatric Health Med Ther. 2019;10:131–139. doi:10.2147/PHMT.S165935
   PubMed Web of Science ®Google Scholar
• Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Curr Opin Pharmacol. 2020;54:72–81. doi:10.1016/j.coph.2020.08.008
   PubMed Web of Science ®Google Scholar
• Ahn JG, Bae Y, Shin D, Nam J, Kim KY, Kim DS. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Rheumatology. 2019;58(5):770–775. doi:10.1093/rheumatology/key356
   PubMed Web of Science ®Google Scholar
• Kim JJ, Yun SW, Yu JJ, et al. Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis. Pharmacogenomics J. 2020;20(1):80–86. doi:10.1038/s41397-019-0085-1
   PubMed Web of Science ®Google Scholar
• Garcia-Pavon S, Yamazaki-Nakashimada MA, Baez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39(6):445–451. doi:10.1097/MPH.0000000000000872
   PubMed Web of Science ®Google Scholar
• Xie T, Wang Y, Fu S, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J. 2017;15(1):17. doi:10.1186/s12969-017-0149-1
   PubMed Web of Science ®Google Scholar
• Nozawa T, Imagawa T, Ito S. Coronary-artery aneurysm in tocilizumab-treated children with Kawasaki’s disease. N Engl J Med. 2017;377(19):1894–1896. doi:10.1056/NEJMc1709609
   PubMed Web of Science ®Google Scholar
• Okada M, Wang CY, Hwang DW, et al. Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ Res. 2002;91(2):135–142. doi:10.1161/01.RES.0000027815.75000.33
   PubMed Web of Science ®Google Scholar
• Khachigian LM, Santiago FS, Rafty LA, et al. GC factor 2 represses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury. Circ Res. 1999;84(11):1258–1267. doi:10.1161/01.RES.84.11.1258
   PubMed Web of Science ®Google Scholar
• Rafty LA, Khachigian LM. Zinc finger transcription factors mediate high constitutive platelet-derived growth factor-B expression in smooth muscle cells derived from aortae of newborn rats. J Biol Chem. 1998;273(10):5758–5764. doi:10.1074/jbc.273.10.5758
   PubMed Web of Science ®Google Scholar
• Cattaruzza M, Nogoy N, Wojtowicz A, Hecker M. Zinc finger motif-1 antagonizes PDGF-BB-induced growth and dedifferentiation of vascular smooth muscle cells. FASEB J. 2012;26(12):4864–4875. doi:10.1096/fj.12-210302
   PubMed Web of Science ®Google Scholar
• Song WM, Agrawal P, Von Itter R, et al. Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis. Nat Commun. 2021;12(1):1214. doi:10.1038/s41467-021-21457-0
   PubMed Web of Science ®Google Scholar
• Kuo HC, Wong HS, Chang WP, et al. Prediction for intravenous immunoglobulin resistance by using weighted genetic risk score identified from genome-wide association study in Kawasaki disease. Circ Cardiovasc Genet. 2017;10(5). doi:10.1161/CIRCGENETICS.116.001625.
   PubMedGoogle Scholar
• Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018;21(1):36–44. doi:10.1111/1756-185X.13224
   PubMed Web of Science ®Google Scholar
• Franco A, Touma R, Song Y, et al. Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity. 2014;47(2):95–104. doi:10.3109/08916934.2013.860524
   PubMed Web of Science ®Google Scholar
• Shrestha S, Wiener H, Shendre A, et al. Role of activating FcgammaR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Circ Cardiovasc Genet. 2012;5(3):309–316. doi:10.1161/CIRCGENETICS.111.962464
   PubMedGoogle Scholar
• Amano Y, Akazawa Y, Yasuda J, et al. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease. Pediatr Rheumatol Online J. 2019;17(1):34. doi:10.1186/s12969-019-0337-2
   PubMed Web of Science ®Google Scholar
• Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J. 2008;27(2):155–160. doi:10.1097/INF.0b013e31815922b5
   PubMed Web of Science ®Google Scholar
• Weiss RJ, Spahn PN, Toledo AG, et al. ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis. Proc Natl Acad Sci USA. 2020;117(17):9311–9317. doi:10.1073/pnas.1920880117
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhangyuan G, Wang F, et al. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation. Immunity. 2021;54(6):1168–1185 e1168. doi:10.1016/j.immuni.2021.04.027
   PubMed Web of Science ®Google Scholar
• Lv L, Zhang J, Wang P, Meng Q, Liang W, Zhang L. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury. J Vasc Surg. 2014;59(2):500–509. doi:10.1016/j.jvs.2013.03.049
   PubMed Web of Science ®Google Scholar
• Cui S, Wang L, Zhao H, Lu F, Wang W, Yuan Z. Benzyl butyl phthalate (BBP) triggers the migration and invasion of hemangioma cells via upregulation of Zeb1. Toxicol In Vitro. 2019;60:323–329. doi:10.1016/j.tiv.2019.06.013
   PubMed Web of Science ®Google Scholar
• Ma L, Chandel N, Ermel R, et al. Multiple independent mechanisms link gene polymorphisms in the region of ZEB2 with risk of coronary artery disease. Atherosclerosis. 2020;311:20–29. doi:10.1016/j.atherosclerosis.2020.08.013
   PubMed Web of Science ®Google Scholar
• Bresson V, Bonello B, Rousset-Rouviere C, et al. Maladie de Kawasaki chez le grand enfant et l’adulte jeune: expe´rience marseillaise sur 10 ans. Arch Pediatr. 2011;18(7):731–736. French. doi:10.1016/j.arcped.2011.04.014
   PubMed Web of Science ®Google Scholar
• Cai Z, Zuo R, Liu Y. Characteristics of Kawasaki disease in older children. Clin Pediatr. 2011;50(10):952–956. doi:10.1177/0009922811409027
   PubMed Web of Science ®Google Scholar
• Fairfax BP, Humburg P, Makino S, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science. 2014;343(6175):1246949. doi:10.1126/science.1246949
   PubMed Web of Science ®Google Scholar
• Fairfax BP, Makino S, Radhakrishnan J, et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet. 2012;44(5):502–510. doi:10.1038/ng.2205
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu Y, Huang P, et al. Homozygous of MRP4 gene rs1751034 C allele is related to increased risk of intravenous immunoglobulin resistance in Kawasaki disease. Front Genet. 2021;12:510350. doi:10.3389/fgene.2021.510350
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu Y, Zhou H, et al. Association between P2RY12 gene polymorphisms and IVIG resistance in Kawasaki patients. Cardiovasc Ther. 2020;2020:3568608. doi:10.1155/2020/3568608
   PubMed Web of Science ®Google Scholar
• Yu H, Liu F, Chen K, et al. The EIF2AK4/rs4594236 AG/GG genotype is a hazard factor of immunoglobulin therapy resistance in southern Chinese Kawasaki disease patients. Front Genet. 2022;13:868159. doi:10.3389/fgene.2022.868159
   PubMed Web of Science ®Google Scholar